SARS-CoV-2, a virus with many faces: a series of cases with prolonged persistence of COVID-19 symptoms
Sofian et al.,
SARS-CoV-2, a virus with many faces: a series of cases with prolonged persistence of COVID-19 symptoms,
Wiener Medizinische Wochenschrift, doi:10.1007/s10354-020-00793-8
Report on a series of 10 patients experiencing prolonged COVID-19 symptoms that were given HCQ 250mg bid for 5 days, with resolution of symptoms in all cases, and patients reporting they felt much better 2 days after treatment initiation.
Sofian et al., 14 Dec 2020, peer-reviewed, 7 authors.
Abstract: short report
Wien Med Wochenschr (2021) 171:3–6
https://doi.org/10.1007/s10354-020-00793-8
SARS-CoV-2, a virus with many faces: a series of cases with
prolonged persistence of COVID-19 symptoms
Masoomeh Sofian · Ali Akbar Velayati · Mohammad Banifazl · Fatemeh Fotouhi · Mona Sadat Larijani ·
Neda Afzali · Amitis Ramezani
Received: 19 June 2020 / Accepted: 16 November 2020 / Published online: 14 December 2020
© Springer-Verlag GmbH Austria, ein Teil von Springer Nature 2020
Summary Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), as the causative agent of
the ongoing pandemic, has spread into more than
200 countries to date. The disease which is caused
by the virus is termed COVID-19. In most cases, it
presents at first like common flu with cough and other
respiratory symptoms. Nevertheless, other symptoms
have been reported, such as a feeling of extreme fatigue, gastrointestinal symptoms, or acute onset of
olfactory and gustatory dysfunction. Here we report
a series of 10 cases (1 male, 9 females) observed between February and April 2020, with an undulating
appearance and disappearance of symptoms. Weeks
passed before the diagnosis was established. Symptoms resolved rapidly after treatment with hydroxyProfessor of Infectious Diseases M. Sofian
Infectious Disease Research Center, Arak University of
Medical Sciences, Arak, Iran
Professor of Pediatrics A. A. Velayati
Masih Daneshvari Hospital, Shahid Beheshti University of
Medical Science, Tehran, Iran
Professor of Pediatrics M. Banifazl
Iranian Society for Support of Patients with Infectious
Disease, Tehran, Iran
Associate Professor of Virology F. Fotouhi
Influenza and other Respiratory Viruses Department,
Pasteur Institute of Iran, Tehran, Iran
M. Sadat Larijani, PhD
Clinical Research Department, Pasteur Institute of Iran,
Tehran, Iran
N. Afzali, Master degree of Government Management
Rapid Reaction Force, Pasteur Institute of Iran, Tehran, Iran
A. Ramezani, MD, PhD ()
Clinical Research Department, Pasteur Institute of Iran,
No:69, Pasteur Ave, 1316943551 Tehran, Iran
amitisramezani@hotmail.com
K
chloroquine. It seems that the course of COVID-19
can be mild or moderate but with a long persistence
of symptoms, and may therefore remain obscure. This
may cause a public health issue because of the long
infectivity of these patients.
Keywords COVID-19 · SARS-CoV-2 · Iran · Prolonged
symptomatology · Public health
Late treatment
is less effective
Please send us corrections, updates, or comments. Vaccines and
treatments are complementary. All practical, effective, and safe means should
be used based on risk/benefit analysis. No treatment, vaccine, or intervention
is 100% available and effective for all current and future variants. We do not
provide medical advice. Before taking any medication, consult a qualified
physician who can provide personalized advice and details of risks and
benefits based on your medical history and situation.
FLCCC and
WCH
provide treatment protocols.
Submit